Clinical Spectrum, Morbidity, and Mortality of Acquired Immunodeficiency Syndrome in Taiwan: A 5-Year Prospective Study
- 1 August 2000
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (4) , 378-385
- https://doi.org/10.1097/00042560-200008010-00013
Abstract
To assess the prevalence and the sociodemographic and behavioral correlates of anal sex in a cohort of HIV-seronegative U.S. women at high risk of HIV exposure, we administered a risk assessment using audio computer-assisted selfinterview (A-CASI). Of 1268 sexually active women, 432 (32%) reported anal sex in the previous 6 months. Compared with women who did not report anal sex, those who did had more unprotected vaginal sex (median of 11 versus 7 episodes; p < .001) and a higher proportion of unprotected sexual (vaginal plus anal) episodes (median of 0.90 versus 0.81; p = .01). Anal sex was reported by higher proportions of women who did not always use condoms, who used crack in the past year, who were ≤35 years of age, with no formal education beyond high school, who had had a diagnosed sexually transmitted disease in the previous year, a primary male sex partner, and a male sex partner with a history of injecting use. Women were more likely to report anal sex by A-CASI than during interviewer-administered risk assessments (odds ratio [OR], 9.00; 95% confidence interval [CI], 1.14-71.0). A less biased method of ascertainment may account for the large proportion of women reporting anal sex. Given increased vaginal risk among women reporting anal sex, the relative importance of anal sex in heterosexual transmission merits further study. Behavioral and biomedical prevention strategies effective for anal as well as vaginal sex are needed. Address correspondence and reprint requests to Michael Gross, SCHARP, Fred Hutchinson Cancer Research Cancer, 1100 Fairview Avenue North, MW-500, Seattle, WA 98109, U.S.A.; email: [email protected] The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Manuscript received December 28, 2000; accepted April 26, 2000. © 2000 Lippincott Williams & Wilkins, Inc.Keywords
This publication has 22 references indexed in Scilit:
- Invasive amoebiasis: an emerging parasitic disease in patients infected with HIV in an area endemic for amoebic infectionAIDS, 1999
- The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infectionAIDS, 1999
- The Incidence and Spectrum of AIDS‐Defining Illnesses in Persons Treated with Antiretroviral DrugsClinical Infectious Diseases, 1998
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral TherapyJAMA, 1998
- Invasive Infection Caused by Penicillium marneffei: An Emerging Pathogen in TaiwanClinical Infectious Diseases, 1998
- Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251AIDS, 1998
- Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centresAIDS, 1997
- Decline in deaths from AIDS due to new antiretroviralsThe Lancet, 1997